Metabolites
Displaying compounds 14551 - 14575 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB01766 | Peonidin 3-O-glucoside 68795-37-9 | 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1lambda4-chromen-1-ylium | C22H23O11 463.4114 | |
| YMDB00012 | Adenylsuccinic acid 19046-78-7 | 2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid | C14H18N5O11P 463.2934 | |
| YMDB00871 | N6-(1,2-Dicarboxyethyl)-AMP 19046-78-7 | (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid | C14H18N5O11P 463.2934 | |
| YMDB01724 | Kaempferol 3-O-glucuronide 22688-78-4 | (2S,3S,4S,5R)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid | C21H18O12 462.3604 | |
| YMDB00238 | 5-Methyltetrahydrofolic acid 134-35-0 | (2R)-2-[(4-{[(2-amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid | C20H25N7O6 459.4558 | |
| YMDB00686 | FMNH2 | {[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-1H,2H,3H,4H,5H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy}phosphonic acid | C17H23N4O9P 458.3597 | |
| YMDB00260 | 5,10-Methylene-THF 31690-11-6 | 2-({4-[(6aR)-1-hydroxy-3-imino-3H,4H,5H,6H,6aH,7H,8H,9H-imidazo[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid | C20H23N7O6 457.4399 | |
| YMDB00848 | (6R)-5,10-methylenetetrahydrofolic acid 3432-99-3 | (2S)-2-({4-[(6aR)-3-amino-1-oxo-1H,2H,5H,6H,6aH,7H,8H,9H-imidazolidino[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid | C20H23N7O6 457.4399 | |
| YMDB13398 | MG(25:0/0:0/0:0) | (2R)-2,3-dihydroxypropyl pentacosanoate | C28H56O4 456.752 | |
| YMDB12677 | DG(10:0/14:0/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl tetradecanoate | C27H52O5 456.708 | |
| YMDB12708 | DG(12:0/12:0/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl dodecanoate | C27H52O5 456.708 | |
| YMDB00515 | (6R)-5,10-Methenyltetrahydrofolic acid | (6aR)-3-amino-8-(4-{[(1S)-1,3-dicarboxypropyl]carbamoyl}phenyl)-1-oxo-1H,2H,5H,6H,6aH,7H,8H-10λ⁵-imidazo[1,5-f]pteridin-10-ylium | C20H22N7O6 456.432 | |
| YMDB00879 | 5,10-Methenyltetrahydrofolate 7444-29-3 | 3-amino-8-(4-{[(1S)-1,3-dicarboxypropyl]carbamoyl}phenyl)-1-oxo-1H,4H,5H,6H,6aH,7H,8H-10λ⁵-imidazo[1,5-f]pteridin-10-ylium | C20H22N7O6 456.432 | |
| YMDB00085 | Flavin Mononucleotide 146-17-8 | {[(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-2H,3H,4H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy}phosphonic acid | C17H21N4O9P 456.3438 | |
| YMDB13399 | MG(25:1(11Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (11Z)-pentacos-11-enoate | C28H54O4 454.736 | |
| YMDB13400 | MG(25:1(9Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (9Z)-pentacos-9-enoate | C28H54O4 454.736 | |
| YMDB12678 | DG(10:0/14:1(11Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (11Z)-tetradec-11-enoate | C27H50O5 454.692 | |
| YMDB12679 | DG(10:0/14:1(9Z)/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl (9Z)-tetradec-9-enoate | C27H50O5 454.692 | |
| YMDB01501 | Ubiquinone 4 4370-62-1 | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohexa-2,5-diene-1,4-dione | C29H42O4 454.6414 | |
| YMDB01763 | Pallidol 105037-88-5 | (1R,8R,9R,16R)-8,16-bis(4-hydroxyphenyl)tetracyclo[7.7.0.0^{2,7}.0^{10,15}]hexadeca-2,4,6,10,12,14-hexaene-4,6,12,14-tetrol | C28H22O6 454.4707 | |
| YMDB16279 | 5,10-methenyltetrahydrofolate mono-L-glutamate | (6aR)-3-amino-8-(4-{[(1S)-1,3-dicarboxypropyl]carbamoyl}phenyl)-1-oxo-1H,2H,5H,6H,6aH,7H,8H-10lambda5-imidazo[1,5-f]pteridin-10-ylium | C20H20N7O6 454.424 | |
| YMDB00561 | (2S)-2-[5-Amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamido]succinic acid 3031-95-6 | 2-({5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1H-imidazol-4-yl}formamido)butanedioic acid | C13H19N4O12P 454.2833 | |
| YMDB00350 | SAICAR 3031-95-6 | (2S)-2-({5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1H-imidazol-4-yl}formamido)butanedioic acid | C13H19N4O12P 454.2833 | |
| YMDB13321 | Lyso-PE(16:0/0:0) | 1-[(2-azaniumylethyl phosphono)oxido]-3-hydroxypropan-2-yl hexadecanoate | C21H44NO7P 453.557 | |
| YMDB13330 | Lyso-PE(0:0/16:0) | 3-[(2-azaniumylethyl phosphono)oxido]-2-hydroxypropyl hexadecanoate | C21H44NO7P 453.557 |